Triplett DAAntiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol1992; 28: 211-15.
6.
Carreras LO, Defreyn G., Machin SJ et al. Arterial thrombosis, intrauterine death and 'lupus' anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet1981; i: 244-6.
7.
Carreras LO, Vermylen JGLupus anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemos1982 ;48:38-40.
8.
Vermylen J., Amout J.Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?J Lab Clin Med1992; 120: 10-12.
9.
Vismara A., Meroni PL, Tincani A. et al. Relationship between anticardiolipin and anti-endothelial antibodies in SLE. Clin Exp Immunol1988; 74: 247-53.
10.
Hasselaar P. , Derksen Rhw, Blokzijl L., de Groot PG.Cross-reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost1990; 63: 169-73.
11.
McGrae KR, de Michele A., Samuels P. et al. Detection of endothelial cell reactive immunoglobulin in patients with antiphospholipid antibodies. Br J Haematol1991; 79: 595-605.
12.
Cervera R., Khamashta MA, Font J. et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity1991; 11: 1-6.
13.
Del Papa N. , Meroni PL, Tincani A. et al. Relationship between antiphospholipid and anti-endothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol1992; 10: 37-42.
14.
Del Papa N., Comforti G., Gambini D. et al. Characterization of antiendothelial cell antibodies in antiphospholipid syndrome. In: Molecular Basis of Human Diseases. Polli EE (ed.), Amsterdam, London, New York, Tokyo, Excerpta Medica, 1993: 67-74.
Del Papa N. , Conforti G., Gambini L. et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol1994; 70: 211-16.
17.
Bevers EM, Galli M.Cofactors involved in the antiphospholipid syndrome. Lupus1992; 1: 51-3.
18.
McNeil HP, Simpson RJ, Chesterman CN, Krilis SAAntiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (Papolipoprotein H). Proc Natl Acad Sci USA1990; 87: 4210-4.
19.
Galli M., Comfurius P., Maasen C. et al. Anticardiolipin antibodies (aCL) directed not to cardiolipin but to a plasma protein cofactor. Lancet1990 ; 335: 1544-7.
20.
Allegri F., Balestrieri G., Cattaneo R. et al. The plasma cofactor and anticardiolipin antibodies. Clin Exp Rheumatol1990; 8: 613-14.
21.
Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T.Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease . Lancet1990; i: 177-8.
22.
Shousboe I.Binding of β2-glycoprotein I to platelets: effect of adenlytate cyclase activity. Thromb Res19890; 19: 225-37.
23.
La Rosa L., Meroni PL, Tincani A. et al. Beta-2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol1994 (in press).
24.
Arvieux J., Roussel B., Jacob MC, Colomb MGMeasurement of antiphospholipid antibodies by ELISA using β-glycoprotein I as antigen. J Immunol Method1991; 143: 223-9.
25.
Viard JP, Amoura Z., Bach JFAssociation of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med1992; 93: 181-6.
26.
Cabral AR, Rodriguez M., Cabiedes J., Alarcon-Segovia D.Antibodies to β2-glycoprotein I associate with antiphospholipid syndrome whether primary (PAPS) or secondary to systemic lupus erythematosus . Arthritis Rheum1993; 6(Suppl.): S242 (abstract).
